Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-24 4:31 pm Sale | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 83,880,935 37.8% | -664,772 (-0.79%) | View |
| 2023-02-10 4:01 pm Purchase | 13G | IMMATICS N V IMTX | dievini Hopp BioTech holding GmbH & Co KG | 17,202,356 26.2% | 1 (+0.00%) | View |
| 2023-02-10 4:01 pm Sale | 13G | AC IMMUNE SA SHS ACIU | dievini Hopp BioTech holding GmbH & Co KG | 16,316,742 19.5% | -1,724,258 (-9.56%) | View |
| 2022-11-14 4:02 pm Sale | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 84,545,707 45.2% | -1,614,683 (-1.87%) | View |
| 2022-05-05 4:01 pm Sale | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 86,160,390 46% | -158,700 (-0.18%) | View |
| 2022-03-17 5:10 pm Purchase | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 86,319,090 46.2% | 396,349 (+0.46%) | View |
| 2022-02-22 06:26 am Sale | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 85,922,741 46% | -158,700 (-0.18%) | View |
| 2022-02-11 4:00 pm Purchase | 13G | IMMATICS N V IMTX | dievini Hopp BioTech holding GmbH & Co KG | 17,202,355 27.3% | 726,282 (+4.41%) | View |
| 2022-01-13 4:14 pm Purchase | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 86,081,441 46% | 11,667 (+0.01%) | View |
| 2021-10-15 1:21 pm Sale | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 86,069,774 46.1% | -1,449,193 (-1.66%) | View |
| 2021-02-12 1:02 pm Purchase | 13G | IMMATICS N V IMTX | dievini Hopp BioTech holding GmbH & Co KG | 16,476,073 26.2% | 16,476,073 (New Position) | View |
| 2021-02-12 10:59 am Sale | 13G | AC IMMUNE SA SHS ACIU | dievini Hopp BioTech holding GmbH & Co KG | 18,041,000 25.1% | -174,750 (-0.96%) | View |
| 2020-08-24 10:44 am Purchase | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 87,518,967 49.2% | 87,518,967 (New Position) | View |
| 2020-02-06 3:16 pm Unchanged | 13G | AC IMMUNE SA SHS ACIU | dievini Hopp BioTech holding GmbH & Co KG | 18,215,750 27% | 0 (Unchanged) | View |